These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38300403)

  • 21. ASO Author Reflections: Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy.
    Feng LH; Zhu YY; Zhou JM; Cong WM; Dong H; Wang L
    Ann Surg Oncol; 2023 Jan; 30(1):373-374. PubMed ID: 36260145
    [No Abstract]   [Full Text] [Related]  

  • 22. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?
    Adam R; Azoulay D
    Ann Surg; 2005 Apr; 241(4):671-2. PubMed ID: 15798471
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Treatment for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus-Anatomic Resection Should Be Recommended.
    Wu JY; Sun JX; Cheng SQ; Yan ML
    Ann Surg Oncol; 2021 Nov; 28(12):7696-7697. PubMed ID: 33791902
    [No Abstract]   [Full Text] [Related]  

  • 24. Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability.
    Lau WY; Lai EC
    Ann Surg Oncol; 2007 Dec; 14(12):3301-9. PubMed ID: 17891443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASO Author Reflections: Laparoscopic R1 Vascular Hepatectomy for Hepatocellular Carcinoma: A Step Forward.
    Libia A; Ferraro V; Memeo R
    Ann Surg Oncol; 2021 Jul; 28(7):3701-3702. PubMed ID: 33611745
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: The Role of Postoperative Adjuvant Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Hepatic Vein Invasion.
    Zhang XP; Cheng SQ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):709-710. PubMed ID: 31468218
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Perspectives of Laparoscopic Hepatectomy with Venous Tumor Thrombectomy for Hepatocellular Carcinoma.
    Onda S; Haruki K; Tsunematsu M; Taniai T; Furukawa K; Kawai H; Ikegami T
    Ann Surg Oncol; 2021 Dec; 28(13):8240-8241. PubMed ID: 34170428
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma in Patients with Impaired Liver Function: Is It Justified?
    Imai K; Baba H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):876-877. PubMed ID: 32761334
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: Is Hepatectomy Plus Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement Justified?
    Orimo T; Kamiyama T; Taketomi A
    Ann Surg Oncol; 2020 Oct; 27(11):4164-4165. PubMed ID: 32578063
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Anatomical Liver Sectionectomy for Centrally Located Hepatocellular Carcinoma.
    Orimo T; Kamiyama T; Taketomi A
    Ann Surg Oncol; 2021 Oct; 28(11):6780-6781. PubMed ID: 33634390
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care.
    Lima HA; Moazzam Z; Endo Y; Pawlik TM
    Ann Surg Oncol; 2023 Aug; 30(8):4600-4601. PubMed ID: 37160806
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Kong J; Li G; Chai J; Yu G; Liu Y; Liu J
    Ann Surg Oncol; 2021 Dec; 28(13):8234-8235. PubMed ID: 34145503
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: Understanding How to Improve Surveillance in Hepatocellular Carcinoma.
    Papageorge MV; Sachs TE
    Ann Surg Oncol; 2022 Dec; 29(13):8432-8433. PubMed ID: 36100835
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: Perspectives in the Measurement of Rapid Turnover Proteins in Patients with Hepatocellular Carcinoma.
    Yanagaki M; Haruki K; Yasuda J; Furukawa K; Onda S; Tsunematsu M; Shirai Y; Gocho T; Taniai T; Hamura R; Ikegami T
    Ann Surg Oncol; 2021 Dec; 28(13):8140-8141. PubMed ID: 34448964
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: The Application of ICG Fluorescent Staining in Laparoscopic Hepatectomy for Liver Malignancies is More Beneficial to Ensure Radical Surgery.
    Cai X; Hong H; Chen Y
    Ann Surg Oncol; 2023 Apr; 30(4):1988-1989. PubMed ID: 36528747
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Association of Ferroptosis with Transferrin Receptor in Hepatocellular Carcinoma.
    Itoh S; Toshida K; Hiromatsu M; Yoshizumi T
    Ann Surg Oncol; 2023 Dec; 30(13):8007-8008. PubMed ID: 37552348
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Optimizing End-of-Life Care for Patients Dying from Hepatocellular Carcinoma.
    Rice DR; Pawlik TM
    Ann Surg Oncol; 2021 Sep; 28(9):5423-5424. PubMed ID: 33521904
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: How to Choose the Optimal Strategy to Treat Patients with Moderately Advanced Multifocal Hepatocellular Carcinomas?
    Zheng J; Long H; Huang Y; Yan L; Yang J; Jiang L; Wu H
    Ann Surg Oncol; 2022 Aug; 29(8):5202-5203. PubMed ID: 35430664
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiofrequency ablation as a salvage procedure for ruptured hepatocellular carcinoma.
    Ng KK; Lam CM; Poon RT; Law WL; Seto CL; Fan ST
    Hepatogastroenterology; 2003; 50(53):1641-3. PubMed ID: 14571805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASO Author Reflections: Does Anatomic Resection Improve Prognosis for Hepatocellular Carcinoma? Assessment from Recurrence Treatment.
    Minagawa M; Mise Y; Saiura A
    Ann Surg Oncol; 2022 Feb; 29(2):922-923. PubMed ID: 34518940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.